Zobrazeno 1 - 10
of 412
pro vyhledávání: '"Moon Suk, Kim"'
Autor:
Kyung Won Lee, Eun Kyeong Yang, Duc Long Nguyen, Soo A Park, Moon Suk Kim, Jae-Ho Kim, Min Young Lee, Hyun C. Yoon
Publikováno v:
Sensing and Bio-Sensing Research, Vol 46, Iss , Pp 100714- (2024)
Integrins are a family of transmembrane receptors that play a crucial role in cell adhesion and migration. Integrins can uniquely transduce biochemical signals bidirectionally across the membrane and physically link the cell-cell and cell-extracellul
Externí odkaz:
https://doaj.org/article/e4fb7db3f96649cbadb3cd83d4630a56
Publikováno v:
Materials Today Bio, Vol 29, Iss , Pp 101284- (2024)
Research in the field of regenerative medicine, which replaces or restores the function of human damaged organs is advancing rapidly. These advances are fostering important innovations in the development of artificial organs. In recent years, three-d
Externí odkaz:
https://doaj.org/article/453de57a1c5c4fe08ad3057be1492d21
Autor:
Hee Eun Kim, Hyeon Jin Ju, Shina Kim, Young Hun Kim, Soyeon Lee, Sangdun Choi, Hyun C. Yoon, Hak Soo Choi, Moon Suk Kim
Publikováno v:
Materials Today Bio, Vol 26, Iss , Pp 101070- (2024)
Endogenous stem cell-driven in situ bone tissue formation has recently garnered increasing attention. Therefore, our study sought to refine methods to enhance the migration and subsequent osteogenic differentiation of these cells. Our innovative appr
Externí odkaz:
https://doaj.org/article/a126dda28c4646cbb1f6ce8817dc4167
Autor:
Yun Bae Ji, Hye Yun Lee, Soyeon Lee, Young Hun Kim, Kun Na, Jae Ho Kim, Sangdun Choi, Moon Suk Kim
Publikováno v:
Materials Today Bio, Vol 16, Iss , Pp 100339- (2022)
Adapalene (AD) is an FDA-approved drug that shows good therapeutic efficacy for the treatment of acne vulgaris. However, due to its negative charge, AD cannot efficiently penetrate across the also negatively-charged skin membrane. This study is the f
Externí odkaz:
https://doaj.org/article/1e7dc33375564e0890cab0598edf25d9
Publikováno v:
Materials Today Bio, Vol 16, Iss , Pp 100386- (2022)
Triple-negative breast cancer (TNBC) patients are considered intractable, as this disease has few effective treatments and a very poor prognosis even in its early stages. Here, intratumoral therapy with resveratrol (Res), which has anticancer and met
Externí odkaz:
https://doaj.org/article/783c147219254cf099a08391ccc850e1
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
The innate immune system is the first line of host’s defense against invading pathogens. Multiple cellular sensors that detect viral components can induce innate antiviral immune responses. As a result, interferons and pro-inflammatory cytokines ar
Externí odkaz:
https://doaj.org/article/da451243cdaf42089a0d44e54c63c6c4
Autor:
Seung Hun Park, Richard S. Kim, Wesley R. Stiles, Minjoo Jo, Lingxue Zeng, Sunghoon Rho, Yoonji Baek, Jonghan Kim, Moon Suk Kim, Homan Kang, Hak Soo Choi
Publikováno v:
Advanced Science, Vol 9, Iss 15, Pp n/a-n/a (2022)
Abstract Deferoxamine (DFO) is an FDA‐approved iron‐chelating agent which shows good therapeutic efficacy, however, its short blood half‐life presents challenges such as the need for repeated injections or continuous infusions. Considering the
Externí odkaz:
https://doaj.org/article/ffeecf6ea8e3426f8638a3a3467f86b8
Autor:
Ka Ram Kim, Danbi Lee, Kwan Young Jeong, Kyung Won Lee, Moon Suk Kim, Jae-Ho Kim, Hyun C. Yoon
Publikováno v:
ACS Omega, Vol 5, Iss 38, Pp 24790-24798 (2020)
Externí odkaz:
https://doaj.org/article/a2a4875603a5484ba63a77435578902b
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 9 (2021)
Toll-like receptors (TLRs) are the pattern recognition receptors, which are activated by foreign and host molecules in order to initiate the immune response. They play a crucial role in the regulation of innate immunity, and several studies have show
Externí odkaz:
https://doaj.org/article/78f0ffe21b544d7da46a82c720a82aca
Autor:
Yun Bae Ji, Soyeon Lee, Hyeon Jin Ju, Hee Eun Kim, Jung Hyun Noh, Sangdun Choi, Kinam Park, Hai Bang Lee, Moon Suk Kim
Publikováno v:
Journal of Controlled Release. 356:43-58